Valtruis: A healthcare investment platform transforming the industry by funding and partnering with innovative leaders.
Location
New York City, NY, US
Founded
2021
Valtruis is a healthcare investment platform focused on partnering with disruptive leaders to transform the industry through value-based care. The firm invests across various stages, from early-stage development to more advanced rounds, and leverages its extensive expertise and network to support the growth of its portfolio companies. Valtruis aims to drive meaningful change in healthcare by funding innovative solutions that challenge the status quo in how care is accessed, delivered, and paid for.
Notable portfolio companies include Axial Healthcare, which has raised $75 million, and InStride Health, with $26 million in funding. The firm is led by a team of seasoned investors and operators with deep roots in the healthcare sector, bringing decades of experience in scaling healthcare enterprises. Valtruis offers unique value-add services, including functional expertise and access to capital, to help their partners evolve into industry-leading enterprises.
Valtruis - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Current Portfolio Count2
Top Investment Stages
Series B1 (50.0%)
Series D1 (50.0%)
Stage Mix
Series B 50%Series D 50%
Concentration shown as share of disclosed investments by stage.
